Stemline Therapeutics Switzerland GmbH
Pharmaceuticals · Zug, Zug
Stemline Therapeutics Switzerland GmbH is a Swiss pharmaceuticals company based in Zug, Canton of Zug, listed in the Swiss commercial register since 2019 (UID CHE-166.416.225).
Board members & signatories
- David Gionco — Vorsitzender der Geschäftsführung
- Florian Baumann Kubetzko — Direktor
- Jeffrey Levitt — Geschäftsführer
Registered purpose
Betreiben, auf jegliche Art, von Handelsgeschäften (Einzel- und Grosshandel), Importieren, Exportieren, Kaufen, Verkaufen und Vertreiben von chemischen Produkten, einschliesslich pharmazeutischer und biopharmazeutischer Produkte oder anderer zusammenhängender (Grundstoffs-)Produkte, Erbringen von operativen und unterstützenden Dienstleistungen an Gruppengesellschaften im Zusammenhang hiermit sowie…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What Stemline Therapeutics Switzerland does
OFFERING
Stemline Therapeutics focuses on the development and commercialization of oncology therapeutics. Their product pipeline includes ELZONRIS® (tagraxofusp-erzs), approved for treating blastic plasmacytoid dendritic cell neoplasm (BPDCN), and ORSERDU™ (elacestrant), indicated for advanced or metastatic breast cancer. Both products are designed to address significant unmet medical needs in oncology.
Unlock the full analysis →Similar companies
- Biogen Switzerland AG — Biotechnology · Baar
- Swiss Bioscience GmbH — Biotechnology · Schlieren
- Swiss Cannabis Pharma AG — Pharmaceuticals · Stansstad
- Leman SKL SA — Pharmaceuticals · Petit-Lancy
- Sintetica SA — Pharmaceuticals · Mendrisio
- Merck (Schweiz) AG — Pharmaceuticals · Zug
Find every pharmaceuticals company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned pharmaceuticals companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime